Healthcare
Sequoia invests in India healthcare services start-up
Sequoia Capital India has invested INR250 million ($4.6 million) into Bangalore-based Practo Technologies, a cloud-based clinic management platform. The Series A round will support the company's global expansion plans.
Southern Capital revises Adventa MBO offer
Southern Capital Group and a director of Adventa have submitted a revised takeover bid for the Malaysian medical products manufacturer. The offer still stands at MYR320.85 ($100 million), or MYR2.10 per share, but now excludes Adventa’s interests in Sun...
IHH raises $2b from IPO, Abraaj Capital exits
IHH Healthcare, the hospital operator owned by Malaysian sovereign wealth fund Khazanah Nasional, has raised MYR6.3 billion ($2 billion) from its IPO after pricing the offering near the top of the indicative range. Abraaj Capital fully exited its holding...
Southern Capital backs Malaysia's Adventa in $100m MBO
Singapore-based Mulberry Asia Fund II, a private equity fund managed by Southern Capital Group, has acquired medical products manufacturer Adventa alongside its present managing director Low Chin Guan. The deal is valued at MYR320.85 million ($100 million)....
TPG backs $176m ShangPharma MBO
TPG Capital is backing a management buyout (MBO) bid for ShangPharma, a Chinese pharmaceutical and biotech research outsourcing firm listed on the New York Stock Exchange. Michael Hui, ShangPharma’s chairman and CEO, and affiliates of TPG have offered...
Hao Capital forms healthcare JV with TCL Group
China-focused private equity firm Hao Capital has formed a joint venture with the TCL Group, one of the leading consumer electronics companies in China, to provide diagnostic imaging products and services.
India's IvyCap Ventures in $19m first close for debut fund
Early-stage investor IvyCap Ventures has reached a first close of INR1.05 billion ($19 million) on its debut fund. The full target for IvyCap Ventures Trust Fund I is INR2 billion.
Quadria Capital to raise a $300m healthcare fund
Quadria Capital is in the process of raising a $300 million fund to tap India's expanding healthcare market. Religare Global Asset Management, a unit of Delhi-based financial services group Religare Enterprises, has become an anchor investor, committing...
Advent Private secures GenesisCare exit through KKR buyout
KKR’s recent buyout of Australian healthcare firm GenesisCare secured an exit for mid-market investor Advent Private Capital. The domestic GP described the exit, which comes after a holding period of just three years, as “highly successful.”
India to launch $360m pharma fund
The Indian government is contemplating launching an INR20 billion ($367 million) venture capital fund to invest in research and development (R&D) in the pharmaceutical sector.
VIDEO: Sterling Partners' Eric Becker
Some private equity firms in emerging Asian markets still shirk at being labeled specialist, arguing that a narrow focus risks missing out on a wealth of growth opportunities. The US, several decades down the line in terms of the private equity development...
KKR takes majority stake in Australia's GenesisCare
KKR has picked up a 63% interest in Australia’s GenesisCare, which provides services to patients with cancer and cardiovascular disease. It represents the latest in a string of healthcare sector deals by private equity firms, with TPG Capital and The...
Indian deal values increase in first quarter - PwC
The value of private equity deals in India jumped 57% during the first three months of this year compared to the fourth quarter of 2011, according to a new report. The number of deals decreased 24% over the same period, however.
Jacob Ballas supports Indian diagnostics chain
The $40 billion Indian healthcare market is growing rapidly and has seen numerous PE investments into hospital chains and pharmaceutical companies. However, the country’s diagnostic expertise and infrastructure still lag behind.
Fortis raises $66m from Jacob Ballas, IFC for Super Religare
Bangalore-based Fortis Healthcare has reached agreements with Jacob Ballas Capital and the International Finance Corporation (IFC) to raise INR3.7 billion ($66.4 million) for its diagnostics unit Super Religare Laboratories (SRL).
Lilly ups stake in Chinese pharma firm
Lilly Asian Ventures, the venture capital arm of pharmaceutical giant Eli Lilly & Co., has injected an additional $20 million of capital into existing portfolio company Novast.
Private investors back IPO of Khazanah's healthcare arm
Blackrock, Capital Group and Och-Ziff Capital Management Group have agreed to become cornerstone investors in the proposed $2 billion IPO of Malaysia's Integrated Healthcare Holdings (IHH), which is owned by Khazanah Nasional.
IFC may back IPO of Khazanah's healthcare arm
International Financial Corp (IFC), the private investment arm of the World Bank, is planning to invest in the proposed $1.5 billion IPO of Malaysia's Integrated Healthcare Holdings (IHH), which is owned by Khazanah Nasional.
Ironbridge targets $1b for Fund III, invests $95m in dental business
Australian private equity house Ironbridge Capital has said it will target up to A$1 billion ($1 billion) for its third fund, for which it will begin fundraising in the second half of this year.
TPG, Carlyle sell Healthscope pathology assets for $100m
TPG Capital and the Carlyle Group have sold the New South Wales, Queensland and Western Australian pathology businesses of their portfolio company, Healthscope, for A$100 million ($100 million). The buyer was pathology and radiology group Sonic Healthcare....
Moolchand raises $18.7m from Sequoia Capital
Sequoia Capital has invested INR1 billion ($18.7 million) into New Delhi-based Moolchand Healthcare, with an aim to fund the company’s further expansion and acquisitions of hospitals across India.
New Zealand's Waterman buys 20% of Manuka Health
New Zealand-based Waterman Capital has acquired a 20% stake in natural health brand Manuka Health.
Unison secures Showa Yakuhin Kako SBO
Unison Capital has emerged victorious in the auction for Showa Yakuhin Kako, securing the secondary buyout of the drug producer from Tokio Marine Capital, Polaris Capital Group and PineBridge Investments.
JAFCO backs US-based pharma company in Series A funding
JAFCO has invested $10 million in the Series A financing of Eleven Biotherapeutics, a US-based biopharmaceutical company designing and engineering novel and differentiated protein-based biotherapeutics.